Global Burden of Bloodstream Infections in COVID-19: Prevalence, Antimicrobial Resistance, and Mortality Risk
BSIs, largely driven by multidrug-resistant pathogens, substantially worsen COVID-19 outcomes. Variability in diagnostic criteria (CDC vs. ECDC) and reliance on retrospective designs are limitations, though moderate heterogeneity (I<sup>2</sup> = 50%) enhances generalizability across diverse populations. Strengthened infection prevention and antimicrobial stewardship are urgently required.
Authors
- Ana-Maria Pah
- Marius Badalica-Petrescu
- Ioana Cotet
- Diana-Maria Mateescu (ORCID: https://orcid.org/0009-0009-4951-1702)
- Adrian Cosmin Ilie (ORCID: https://orcid.org/0000-0002-8533-4856)
- Stela Iurciuc (ORCID: https://orcid.org/0000-0003-3536-6099)
- Maria-Laura Craciun
- Camelia-Oana Mureșan (ORCID: https://orcid.org/0009-0006-3896-9599)
- Cristina Guse
- Alexandra Enache (ORCID: https://orcid.org/0000-0003-4425-5876)
- Adina Avram (ORCID: https://orcid.org/0009-0003-7868-9266)
Institutions
- Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
- Institute e-Austria Timisoara (RO)
Publication Details
- Journal
- Viruses
- Published
- 2025-10-09
- DOI
- https://doi.org/10.3390/v17101353
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00